Abstract
Molecular Response with Nilotinib in Patients with Philadelphia Negative (Ph-) Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENEST1st Sub-Analysis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have